PFKM and neoplasm: Knockdown of the enzyme phosphofructokinase-m (PFK-m) before tumor engraftment on mice reverted PD-1 expression on CD8+ TILs and the corresponding PD-L1 on tumor cells suggesting that this phenomenon was mediated by the high glycolytic activity of PDAC cells (26).